[HTML][HTML] Virological confirmation of suspected dengue in a phase 2 Latin American vaccine trial: implications for vaccine efficacy evaluation
M Boaz, H Janosczyk, S Garg, S Yost, SW Hildreth… - Trials in …, 2014 - Elsevier
The CYD tetravalent dengue vaccine candidate is being evaluated for protective efficacy
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …
Virological confirmation of suspected dengue in a Phase 2 Latin American vaccine trial: Implications for vaccine efficacy evaluation
M Boaz, H Janosczyk, S Garg, S Yost, SW Hildreth… - Trials in …, 2014 - infona.pl
The CYD tetravalent dengue vaccine candidate is being evaluated for protective efficacy
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …
Virological confirmation of suspected dengue in a Phase 2 Latin American vaccine trial: implications for vaccine efficacy evaluation.
M Boaz, H Janosczyk, S Garg, S Yost, SW Hildreth… - 2014 - cabidigitallibrary.org
The CYD tetravalent dengue vaccine candidate is being evaluated for protective efficacy
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …
Virological confirmation of suspected dengue in a Phase 2 Latin American vaccine trial: Implications for vaccine efficacy evaluation
M Boaz, H Janosczyk, S Garg, S Yost, SW Hildreth… - Trials in …, 2014 - infona.pl
The CYD tetravalent dengue vaccine candidate is being evaluated for protective efficacy
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …
against symptomatic dengue in Phase 3 efficacy trials. The laboratory test algorithm to …